• Open Account

Goldline Pharmaceutical Limited IPO

IPO Details

Issue Size

27

Price Range

₹41.00 - 43.00

Lot Size

3,000

Min Investment

₹2,58,000

Face Value

Issue Type

IPO

Exchange

BSE

ISIN

INE1CLW01015

GMP

-

IPO Timeline

Bidding Opens 12-05-2026
Bidding Closes 14-05-2026
Allotment Date 15-05-2026
Refund Initiation 18-05-2026
Listing Date 19-05-2026

Goldline Pharmaceutical Limited Lot Size

Application Lots Shares Amount
Retail (Min) 1 3000 ₹2,58,000
Retail (Max) 2 6000 ₹5,16,000
HNI (Min) 3 9000 ₹7,74,000

FAQs on Goldline Pharmaceutical Limited IPO

What are allotment date for the Goldline Pharmaceutical Limited ?

Allotment: 15-05-2026

What are the open and close dates for the Goldline Pharmaceutical Limited IPO ?

Opens on 12-05-2026, closes on 14-05-2026.

Can NRIs apply for the Goldline Pharmaceutical Limited IPO through PL Capital?

Yes, NRIs can apply for the Goldline Pharmaceutical Limited IPO through PL Capital, subject to RBI and SEBI guidelines. Applications can be made via the NRE or NRO account route.

Where is the Goldline Pharmaceutical Limited IPO getting listed?

The Goldline Pharmaceutical Limited IPO will be listed on BSE. The exact listing date is 19-05-2026.

What is the minimum and maximum investment allowed in the Goldline Pharmaceutical Limited IPO?

The minimum investment for retail investors in the Goldline Pharmaceutical Limited IPO is ₹2,58,000. The maximum retail investment allowed is ₹5,16,000.

What is the GMP for this IPO?

Current GMP is - (-)

App QR Code

Download the PL Capital App

Open Demat Account
×